EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Renal Proximal Tubule Cells in Obesity-Related Glomerulopathy

Muyao Ye, Ming Yang, Wenni Dai, Hao Li, Xun Zhou, Yinyin Chen, Liyu He iD

Pharmaceuticals · 05.09.2023 · 16 (9) · 1256

DOI: 10.3390/ph16091256 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 05.09.2023. Verfasst von Muyao Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, Chang…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Hunan Provincial Natural Science Foundation for Outstanding Youth, Scientific Research Project of Hunan Provincial Health Commission, Hunan Provincial Natural Science Foundation for Outstanding Youth.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a metabolic disorder, obesity can cause secondary kidney damage, which is called obesity-related glomerulopathy (ORG). As the incidence of obesity increases worldwide, so does the incidence of end-stage renal disease (ESRD) caused by ORGs. However, there is still a lack of effective strategies to prevent and delay the occurrence and development of ORG. Therefore, a deeper understanding and elaboration of the pathogenesis of ORG is conducive to the development of therapeutic drugs for ORG. Here, we review the characteristics of pathological lesions of ORG and describe the roles of lipid metabolism disorders and mitochondrial oxidative stress in the development of ORG. Finally, we summarize the current available drugs or compounds for the treatment of ORG and suggested that ameliorating renal lipid metabolism and mitochondrial function may be potential therapeutic targets for ORG.

Schlagwörter

Stichwörter der Autor:innen

lipid metabolismobesity-related glomerulopathyoxidative stressrenal proximal tubule cells

Autor:innen und Institutionen

  • Department of Nephrology, The Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha 410011, China.
  • Department of Nephrology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410081, China.
  • Changsha Clinical Research, Changsha 410011, China.

ORCID-Profile: Liyu He

Förderung

  • the Hunan Provincial Natural Science Foundation for Outstanding Youth
  • Scientific Research Project of Hunan Provincial Health Commission
  • Hunan Provincial Natural Science Foundation for Outstanding Youth
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Ye, M., Yang, M., Dai, W., Li, H., Zhou, X., Chen, Y., & He, L. (2023). Targeting Renal Proximal Tubule Cells in Obesity-Related Glomerulopathy. Pharmaceuticals, 16(9), 1256. https://doi.org/10.3390/ph16091256

Vancouver

Ye M, Yang M, Dai W, Li H, Zhou X, Chen Y, et al. Targeting Renal Proximal Tubule Cells in Obesity-Related Glomerulopathy. Pharmaceuticals. 2023;16(9):1256. doi:10.3390/ph16091256

BibTeX
@article{Ye2023,
  author = {Ye, Muyao and Yang, Ming and Dai, Wenni and Li, Hao and Zhou, Xun and Chen, Yinyin and He, Liyu},
  title = {Targeting Renal Proximal Tubule Cells in Obesity-Related Glomerulopathy},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {9},
  pages = {1256},
  doi = {10.3390/ph16091256}
}
Kostenlos starten →